Development and validation of a nomogram based on tumor margin irregularity and alpha-fetoprotein for predicting microvascular invasion in hepatocellular carcinoma - Quiz - MDSpire

Development and validation of a nomogram based on tumor margin irregularity and alpha-fetoprotein for predicting microvascular invasion in hepatocellular carcinoma

  • By

  • Xiang Huang

  • Xiaofeng Chen

  • Xiangguang Chen

  • Ruibin Huang

  • Zhuozhi Dai

  • Ruyao Zhuang

  • Zhiqi Yang

  • June 26, 2026

  • 0 min

Share

Original Source(s)

Development and validation of a nomogram based on tumor margin irregularity and alpha-fetoprotein for predicting microvascular invasion in hepatocellular carcinoma

  • by Xiang Huang, Xiaofeng Chen, Xiangguang Chen, Ruibin Huang, Zhuozhi Dai, Ruyao Zhuang, Zhiqi Yang

  • June 26, 2026

Related Content

Comparative effectiveness and safety of adjuvant trastuzumab plus pertuzumab versus trastuzumab emtansine in HER2-positive breast cancer with residual disease after neoadjuvant therapy: a real-world retrospective study

Prehabilitation in cancer care: an evolving field

ESMO Breast Cancer 2026 Highlights: SERENA-6

Harold Burstein, MD, PhD, and Erica Mayer, MD, MPH discuss results from the SERENA-6 trial, which were presented at the 2026 ESMO Breast Cancer Congress.

  • June 26, 2026

  • 1 min